Insights On Clinical Technologies
-
Perspective On The FDA's Final Digital Health Technologies Guidance
1/24/2024
Review the final release of "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”, where the FDA acknowledges DHT value and the increasing use of them in clinical trials.
-
Where Automation And Interoperability Transform Clinical Trials
2/27/2025
In this Clinical Leader Solutions Expo presentation, OpenClinica showcased how advanced automation and seamless interoperability simplify workflows, reduce errors, and free site staff to focus on research and patient care.
-
How Digital Innovation Can Inform RWE-Led Decision-Making
1/17/2025
Real-world evidence (RWE) is changing how healthcare products are developed and marketed. Learn how digital innovations are helping companies leverage RWE to make better decisions.
-
How Partnership Ensured A Successful First Digital Trial
5/1/2024
Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.
-
Evolving Data Review With AI
2/25/2025
AI is transforming clinical data review by automating processes and enhancing efficiency. Discover the four stages of evolution that emphasize automation, regulatory alignment, data analysis, and human oversight.
-
The Scoop On The SCOPE Summit
2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
Revolutionizing Clinical Analytics
3/4/2025
In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.
-
Right-Size Your eConsent Approach
11/17/2023
Delve into the art of tailoring the eConsent experience to match your study and patients' specific needs, such as crafting eConsent documents, selecting appropriate delivery models, and more.
-
Experts Discuss AI's Future In Pharma
5/1/2024
At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.
-
Recap – Optimizing Pediatric Trials To Generate High-Quality Data
3/20/2024
In pediatric trials, leading pediatric clinical research expert Dr. Joan Busner explains that age and cognitive differences make COA measurement more complex and harder to standardize.